X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-21 | PGR | Progressive Corp/Oh/ | Quigg Andrew J | Chief Strategy Officer | S - Sale | $204.35 | -1,649 | 39,626 | -4% | -$336,973 | ||||||
| AD | 2025-12-12 | OGEN | Oragenics Inc | Telling Fred | Dir | S - Sale+OE | $0.94 | -210 | 948 | -18% | -$198 | |||||
| M | 2026-01-20 | ECAT | Blackrock Esg Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% | S - Sale | $15.38 | -272,613 | 25,798,288 | -1% | -$4,193,816 | |||||
2026-01-21 | PGR | Progressive Corp/Oh/ | Bauer Jonathan S. | Chief Investment Officer | S - Sale | $204.35 | -3,105 | 26,371 | -11% | -$634,507 | ||||||
2026-01-20 | GWRE | Guidewire Software, Inc. | Rosenbaum Michael George | CEO | S - Sale | $156.26 | -1,200 | 235,543 | -1% | -$187,512 | ||||||
| D | 2026-01-20 | UBER | Uber Technologies, Inc | West Tony | See Remarks | S - Sale+OE | $83.50 | -3,125 | 176,584 | -2% | -$260,938 | |||||
| D | 2026-01-20 | NEO | Neogenomics Inc | Stone Warren | Pres, COO | S - Sale+OE | $12.50 | -22,128 | 121,631 | -15% | -$276,682 | |||||
2026-01-20 | OLMA | Olema Pharmaceuticals, Inc. | Harmon Cyrus | Dir | S - Sale | $26.88 | -10,000 | 844,798 | -1% | -$268,800 | ||||||
2026-01-20 | IBRX | Immunitybio, Inc. | Simon Barry J. | Dir | S - Sale | $7.20 | -151,967 | 3,091,604 | -5% | -$1,094,297 | ||||||
| DM | 2026-01-16 | IBRX | Immunitybio, Inc. | Selecky Christobel | Dir | S - Sale+OE | $5.84 | -75,000 | 0 | -100% | -$437,650 | |||||
2026-01-16 | SRRK | Scholar Rock Holding Corp | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | S - Sale | $44.48 | -8,406 | 100,558 | -8% | -$373,880 | ||||||
2026-01-16 | SRRK | Scholar Rock Holding Corp | Parlavecchio Caryn | CHRO | S - Sale | $44.48 | -6,600 | 148,864 | -4% | -$293,553 | ||||||
2026-01-16 | SRRK | Scholar Rock Holding Corp | Marantz Jing L. | Chief Medical Officer | S - Sale | $44.48 | -5,798 | 95,687 | -6% | -$257,882 | ||||||
2026-01-16 | SRRK | Scholar Rock Holding Corp | Ho Junlin | GC | S - Sale | $44.48 | -8,016 | 214,553 | -4% | -$356,533 | ||||||
| M | 2026-01-16 | FSLY | Fastly, Inc. | Compton Charles Lacey III | CEO | S - Sale | $8.98 | -13,682 | 612,232 | -2% | -$122,890 | |||||
2026-01-20 | FSLY | Fastly, Inc. | Bergman Artur | CTO | S - Sale | $8.18 | -20,000 | 7,100,828 | 0% | -$163,600 | ||||||
| D | 2026-01-16 | BLK | Blackrock, Inc. | Small Martin | CFO, Senior MD | S - Sale+OE | $1,171.14 | -27,047 | 10,557 | -72% | -$31,675,813 | |||||
2026-01-16 | LC | Lendingclub Corp | Armstrong Annie | Chief Risk Officer | S - Sale | $20.38 | -6,666 | 383,528 | -2% | -$135,853 | ||||||
| DM | 2026-01-20 | SER | Serina Therapeutics, Inc. | Moreadith Randall | Chief Scientific Officer | S - Sale+OE | $3.04 | -4,000 | 0 | -100% | -$12,140 | |||||
2026-01-16 | OUST | Ouster, Inc. | Chung Megan | GC, Secretary | S - Sale | $27.24 | -5,837 | 183,141 | -3% | -$159,000 | ||||||
| M | 2026-01-20 | OM | Outset Medical, Inc. | Nash Marc | EVP Operations R, D, Service | S - Sale | $5.10 | -6,355 | 41,805 | -13% | -$32,400 | |||||
| M | 2026-01-20 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $5.11 | -10,494 | 35,777 | -23% | -$53,599 | |||||
| D | 2026-01-20 | IRON | Disc Medicine, Inc. | Khara Rahul | GC | S - Sale+OE | $69.74 | -1,000 | 37,793 | -3% | -$69,740 | |||||
| M | 2026-01-20 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $5.11 | -13,914 | 147,953 | -9% | -$71,091 | |||||
2026-01-21 | PB | Prosperity Bancshares Inc | Holmes Ned S | Dir | S - Sale | $74.29 | -1,100 | 311,918 | 0% | -$81,716 | ||||||
2026-01-20 | ZIP | Ziprecruiter, Inc. | Sakamoto Ryan T. | EVP, GC | S - Sale | $2.62 | -2,169 | 196,298 | -1% | -$5,673 | ||||||
2026-01-20 | ZIP | Ziprecruiter, Inc. | Garefis Amy | EVP, Chief People Officer | S - Sale | $2.64 | -2,847 | 211,578 | -1% | -$7,521 | ||||||
2026-01-20 | ZIP | Ziprecruiter, Inc. | Shimanovsky Boris F. | EVP, CTO | S - Sale | $2.61 | -5,650 | 336,287 | -2% | -$14,739 | ||||||
2026-01-16 | ZM | Zoom Communications, Inc. | Bawa Aparna | COO | S - Sale | $81.37 | -12,137 | 1,978 | -86% | -$987,553 | ||||||
| M | 2026-01-16 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% | S - Sale | $4.97 | -32,474 | 617,824 | -5% | -$161,520 | |||||
2026-01-20 | GDYN | Grid Dynamics Holdings, Inc. | Livschitz Leonard | CEO | S - Sale | $9.00 | -10,000 | 3,137,203 | 0% | -$90,000 | ||||||
| M | 2026-01-19 | LNWO | Light & Wonder, Inc. | Fine Capital Partners, L.P. | 10% | S - Sale | $120.39 | -30,501 | 8,166,686 | 0% | -$3,671,928 | |||||
| D | 2026-01-16 | IR | Ingersoll Rand Inc. | Reynal Vicente | See Remarks | S - Sale+OE | $88.12 | -191,000 | 438,488 | -30% | -$16,830,920 | |||||
2026-01-20 | GEVO | Gevo, Inc. | Shafer Andrew | Chief Cust Mkt, Brnd Officer | S - Sale | $1.99 | -5,000 | 280,611 | -2% | -$9,940 | ||||||
2026-01-20 | TEAM | Atlassian Corp | Cannon-Brookes Michael | CEO, Co-Founder, 10% | S - Sale | $118.19 | -7,665 | 375,585 | -2% | -$905,916 | ||||||
2026-01-20 | TEAM | Atlassian Corp | Farquhar Scott | Dir, 10% | S - Sale | $118.19 | -7,665 | 375,585 | -2% | -$905,916 | ||||||
2026-01-20 | PTGX | Protagonist Therapeutics, Inc | Molina Arturo Md | Chief Medical Officer | S - Sale | $82.48 | -9,514 | 97,266 | -9% | -$784,715 | ||||||
2026-01-20 | ESPR | Esperion Therapeutics, Inc. | Looker Benjamin | GC | S - Sale | $2.88 | -1,689 | 384,216 | 0% | -$4,868 | ||||||
2026-01-20 | PTGX | Protagonist Therapeutics, Inc | Patel Dinesh V Ph D | Pres, CEO | S - Sale | $82.48 | -34,438 | 580,505 | -6% | -$2,840,446 | ||||||
2026-01-20 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | S - Sale | $82.48 | -8,588 | 78,077 | -10% | -$708,338 | ||||||
| D | 2026-01-21 | WDC | Western Digital Corp | Tregillis Cynthia L | GC, Corp Sec | S - Sale+OE | $229.00 | -447 | 143,318 | 0% | -$102,363 | |||||
| D | 2026-01-20 | NET | Cloudflare, Inc. | Seifert Thomas J | CFO | S - Sale+OE | $178.37 | -10,000 | 137,486 | -7% | -$1,783,682 | |||||
| D | 2026-01-20 | AGX | Argan Inc | Jeffrey John Ronald Jr. | Dir | S - Sale+OE | $380.60 | -2,700 | 21,192 | -11% | -$1,027,620 | |||||
2026-01-16 | AGX | Argan Inc | Leimkuhler William F. | Dir | S - Sale | $379.15 | -11,044 | 49,939 | -18% | -$4,187,333 | ||||||
2026-01-20 | EVER | Everquote, Inc. | Mendal Jayme | CEO, Pres | S - Sale | $24.15 | -14,360 | 406,404 | -3% | -$346,794 | ||||||
2026-01-16 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $6.62 | -4,836 | 1,912,273 | 0% | -$32,014 | ||||||
2026-01-16 | SGHT | Sight Sciences, Inc. | Rodberg James | CFO | S - Sale | $6.62 | -2,616 | 151,230 | -2% | -$17,318 | ||||||
2026-01-16 | CBDS | Dogecoin Cash, Inc. | Tobias David | CEO, 10% | S - Sale | $0.02 | -430,551 | 25,828,000 | -2% | -$8,343 | ||||||
2026-01-16 | SGHT | Sight Sciences, Inc. | Badawi Paul | Pres, CEO, 10% | S - Sale | $6.62 | -22,362 | 6,025,840 | 0% | -$148,036 | ||||||
2026-01-16 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale | $6.62 | -6,308 | 267,611 | -2% | -$41,759 | ||||||
| DM | 2026-01-16 | UWMC | Uwm Holdings Corp | Mat Ishbia | Pres, CEO, 10% | S - Sale+OE | $5.87 | -1,898,622 | 5,599,624 | -25% | -$11,144,911 | |||||
2026-01-21 | IPGP | Ipg Photonics Corp | Scherbakov Eugene A | Dir, 10% | S - Sale | $80.96 | -2,700 | 59,330 | -4% | -$218,586 | ||||||
| M | 2026-01-16 | IPGP | Ipg Photonics Corp | Ip Fibre Devices Ltd | 10% | S - Sale | $80.22 | -64,167 | 6,593,169 | -1% | -$5,147,715 | |||||
2026-01-16 | GS | Goldman Sachs Group Inc | Viniar David A | Dir | S - Sale | $971.13 | -3,390 | 172,693 | -2% | -$3,292,137 | ||||||
| D | 2026-01-16 | GS | Goldman Sachs Group Inc | Viniar David A | Dir | S - Sale+OE | $965.00 | -64,796 | 653,390 | -9% | -$62,528,399 | |||||
2026-01-21 | OUT | Outfront Media Inc. | Diaz Manuel A. | Dir | S - Sale | $24.49 | -11,271 | 47,515 | -19% | -$276,027 | ||||||
2026-01-16 | TG | Tredegar Corp | Gottwald James T. | 10% | S - Sale | $8.57 | -13,887 | 1,707,553 | -1% | -$119,053 | ||||||
2026-01-16 | TG | Tredegar Corp | Gottwald John D | 10% | S - Sale | $8.57 | -13,887 | 3,588,146 | 0% | -$119,053 | ||||||
2026-01-16 | TG | Tredegar Corp | Gottwald William M | 10% | S - Sale | $8.57 | -13,886 | 1,785,011 | -1% | -$119,045 | ||||||
| D | 2026-01-16 | DAL | Delta Air Lines, Inc. | Snell Erik Storey | EVP, Chief Cust Exper Officer | S - Sale+OE | $71.02 | -39,420 | 35,625 | -53% | -$2,799,411 | |||||
2026-01-21 | ABEO | Abeona Therapeutics Inc. | Alvino Mark | Dir | S - Sale | $5.23 | -13,500 | 48,752 | -22% | -$70,574 | ||||||
| D | 2026-01-20 | GILD | Gilead Sciences, Inc. | Bluestone Jeffrey | Dir | S - Sale+OE | $123.50 | -5,000 | 8,920 | -36% | -$617,500 | |||||
| M | 2026-01-16 | VTS | Vitesse Energy, Inc. | Gerrity Robert W | CEO | S - Sale | $19.44 | -113,708 | 1,199,164 | -9% | -$2,210,504 | |||||
| D | 2026-01-20 | HIMS | Hims & Hers Health, Inc. | Okupe Oluyemi | CFO | S - Sale+OE | $30.34 | -9,067 | 99,470 | -8% | -$275,114 | |||||
| M | 2026-01-16 | VTS | Vitesse Energy, Inc. | Cree Brian | Pres | S - Sale | $19.36 | -39,264 | 464,225 | -8% | -$760,291 | |||||
| M | 2026-01-16 | TSQ | Townsquare Media, Inc. | Hellum Erik | COO | S - Sale | $5.55 | -13,959 | 969,648 | -1% | -$77,529 | |||||
2026-01-20 | APLS | Apellis Pharmaceuticals, Inc. | Baumal Caroline | Chief Medical Officer | S - Sale | $19.79 | -1,882 | 89,324 | -2% | -$37,250 | ||||||
2026-01-20 | APLS | Apellis Pharmaceuticals, Inc. | Chopas James George | VP, Chief Accounting Officer | S - Sale | $19.79 | -726 | 51,869 | -1% | -$14,370 | ||||||
2026-01-20 | APLS | Apellis Pharmaceuticals, Inc. | Delong Mark Jeffrey | Chief Business, Strat Officer | S - Sale | $19.79 | -1,334 | 81,724 | -2% | -$26,404 | ||||||
2026-01-20 | APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | S - Sale | $19.79 | -909 | 1,157,310 | 0% | -$17,992 | ||||||
2026-01-16 | FROG | Jfrog Ltd | Landman Yoav | CTO | S - Sale | $57.71 | -45,000 | 5,868,641 | -1% | -$2,596,950 | ||||||
2026-01-20 | APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | CEO | S - Sale | $19.79 | -8,182 | 1,627,659 | -1% | -$161,946 | ||||||
2026-01-20 | APLS | Apellis Pharmaceuticals, Inc. | Nicholson Nur | Chief Technical Officer | S - Sale | $19.79 | -2,203 | 78,843 | -3% | -$43,604 | ||||||
2026-01-16 | FOA | Finance of America Companies Inc. | Thornock Tai A. | Chief Accounting Officer | S - Sale | $24.58 | -1,100 | 10,650 | -9% | -$27,038 | ||||||
2026-01-20 | APLS | Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | CFO | S - Sale | $19.79 | -2,892 | 164,584 | -2% | -$57,241 | ||||||
| D | 2026-01-20 | EQH | Equitable Holdings, Inc. | Pearson Mark | Pres, CEO | S - Sale+OE | $46.20 | -39,700 | 652,945 | -6% | -$1,834,298 | |||||
| M | 2026-01-20 | IDCC | Interdigital, Inc. | Chen Lawrence Liren | Pres, CEO | S - Sale | $315.24 | -5,950 | 159,035 | -4% | -$1,875,678 | |||||
2026-01-16 | OFIX | Orthofix Medical Inc. | Andrews Julie | CFO | S - Sale | $14.38 | -4,873 | 58,039 | -8% | -$70,074 | ||||||
2026-01-20 | APLS | Apellis Pharmaceuticals, Inc. | Watson David O. | GC | S - Sale | $19.79 | -2,475 | 156,499 | -2% | -$48,987 | ||||||
| D | 2026-01-20 | TVTX | Travere Therapeutics, Inc. | Reed Elizabeth E | GC, GC | S - Sale+OE | $27.34 | -10,000 | 90,270 | -10% | -$273,420 | |||||
2026-01-20 | ACN | Accenture Plc | Clifford Katherine Lee | Chief Leadership, HR Officer | S - Sale | $280.63 | -681 | 6,815 | -9% | -$191,108 | ||||||
| D | 2026-01-20 | MIRM | Mirum Pharmaceuticals, Inc. | Quan Joanne | CHIEF MEDICAL OFFICER | S - Sale+OE | $90.27 | -6,911 | 11,305 | -38% | -$623,853 | |||||
2026-01-20 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $101.85 | -5,000 | 4,492,950 | 0% | -$509,225 | ||||||
2026-01-20 | BEAM | Beam Therapeutics Inc. | Cavanagh Bethany J | SVP, Finance, Treasurer | S - Sale | $30.12 | -3,034 | 41,011 | -7% | -$91,384 | ||||||
2026-01-21 | DTI | Drilling Tools International Corp | Domino Michael Wayne Jr. | Pres, DTR Division | S - Sale | $4.00 | -24,996 | 1,433,054 | -2% | -$99,984 | ||||||
| D | 2026-01-16 | KRUS | Kura Sushi Usa, Inc. | Uba Hajime | SEE REMARKS (a) | S - Sale+OE | $72.93 | -9,874 | 6,026 | -62% | -$720,131 | |||||
| D | 2026-01-20 | VICR | Vicor Corp | D'Amico Andrew | Dir | S - Sale+OE | $155.00 | -200 | 0 | -100% | -$31,000 | |||||
2026-01-20 | JBHT | Hunt J B Transport Services Inc | Hobbs Nicholas | EVP, COO | S - Sale | $201.97 | -3,038 | 115,065 | -3% | -$613,582 | ||||||
2026-01-21 | XCUR | Exicure, Inc. | Exicure Hitron Inc. | 10% | S - Sale | $4.50 | -258,367 | 1,598,947 | -14% | -$1,162,652 | ||||||
2026-01-20 | SYNA | Synaptics Inc | Patel Rahul G. | See remarks below | S - Sale | $87.21 | -2,281 | 113,601 | -2% | -$198,925 | ||||||
2026-01-16 | DRI | Darden Restaurants Inc | Wilkerson John W. | Pres Elect, Olive Garden | S - Sale | $213.00 | -2,258 | 18,390 | -11% | -$480,954 | ||||||
| DM | 2026-01-15 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO | S - Sale+OE | $13.59 | -138,167 | 3,379,465 | -4% | -$1,878,094 | |||||
| DM | 2026-01-15 | AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-CEO | S - Sale+OE | $13.59 | -138,188 | 3,379,398 | -4% | -$1,877,570 | |||||
2026-01-15 | NRGV | Energy Vault Holdings, Inc. | Softbank Vision Fund (Aiv M2) L.P. | 10% | S - Sale | $5.65 | -3,000,000 | 15,535,631 | -16% | -$16,950,000 | ||||||
2026-01-15 | FBK | Fb Financial Corp | McPherson James Austin | 10% | S - Sale | $60.06 | -8,500 | 7,063,425 | 0% | -$510,510 | ||||||
2026-01-15 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | S - Sale | $35.92 | -20,961 | 0 | -100% | -$752,833 | ||||||
| D | 2026-01-20 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | S - Sale+OE | $32.10 | -416 | 50,437 | -1% | -$13,354 | |||||
| D | 2026-01-15 | EXPO | Exponent Inc | Corrigan Catherine | Pres, CEO | S - Sale+OE | $72.52 | -1,663 | 92,723 | -2% | -$120,594 | |||||
| D | 2026-01-16 | IONS | Ionis Pharmaceuticals Inc | Swayze Eric | EVP Research | S - Sale+OE | $75.34 | -9,933 | 42,253 | -19% | -$748,383 | |||||
| D | 2026-01-16 | IONS | Ionis Pharmaceuticals Inc | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $75.59 | -9,302 | 63,890 | -13% | -$703,138 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |